CXCL8 in thyroid disease: From basic notions to potential applications in clinical practice

详细信息    查看全文

• 作者：Mario Rotondi ; Francesca Coperchini ; Luca Chiovato
• 关键词：Thyrocytes ; Chemokines ; CXCL8 ; Thyroid cancer ; Autoimmune thyroid disease
• 刊名：Cytokine and Growth Factor Reviews
• 出版年：December, 2013
• 年：2013
• 卷：24
• 期：6
• 页码：539-546
• 全文大小：904 K

文摘

CXCL8 was the first chemokine shown to be secreted by thyrocytes. Experimental data suggest that CXCL8 plays a role in thyroid homeostasis but its role in thyroid diseases remains poorly investigated. Clinical studies measuring the serum levels of CXCL8 in patients with autoimmune-thyroid-diseases reported conflicting results. Solid evidences support a role of CXCL8 as a tumor-promoting agent in several human cancers. Studies in thyroid cancer are still in their initial stage, but promising. Several evidences indicate that thyroid cancer may share with other human malignancies some of the effects of CXCL8 and highlight the possibility of using CXCL8 as a marker of aggressiveness. Basic and clinical evidences in favor or against a role for CXCL8 in thyroid diseases are discussed.